Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120271) titled 'A Two-Way Nested Case-Control Study on the Diagnosis of Sensitivity to Neoadjuvant Chemotherapy Combined with Immunotherapy in Advanced Gastric Cancer Based on Proteomics/Phosphoproteomics' on March 11.
Study Type: Observational study
Study Design:
Nested case-control study
Primary Sponsor: Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine
Condition:
Gastric Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Observation group:270;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showpro...